Nuclear-Encoded Lncrna MALAT1 Epigenetically Controls Metabolic Reprogramming in HCC Cells Through the Mitophagy Pathway
Yijing Zhao,Lei Zhou,Hui Li,Tingge Sun,Xue Wen,Xueli Li,Ying Meng,Yan Li,Mengmeng Liu,Shanshan Liu,Su-Jeong Kim,Jialin Xiao,Lingyu Li,Songling Zhang,Wei Li,Pinchas Cohen,Andrew R. Hoffman,Ji-Fan Hu,Jiuwei Cui
DOI: https://doi.org/10.1016/j.omtn.2020.09.040
IF: 10.183
2020-01-01
Molecular Therapy — Nucleic Acids
Abstract:Mitochondrial dysfunction is a metabolic hallmark of cancer cells. In search of molecular factors involved in this dysregulation in hepatocellular carcinoma (HCC), we found that the nuclear-encoded long noncoding RNA (lncRNA) MALAT1 (metastasis-associated lung adenocarcinoma transcript 1) was aberrantly enriched in the mitochondria of hepatoma cells. Using RNA reverse transcription-associated trap sequencing (RAT-seq), we showed that MALAT1 interacted with multiple loci on mitochondrial DNA (mtDNA), including D-loop, COX2, ND3, and CYTB genes. MALAT1 knockdown induced alterations in the CpG methylation of mtDNA and in mitochondrial transcriptomes. This was associated with multiple abnormalities in mitochondrial function, including altered mitochondrial structure, low oxidative phosphorylation (OXPHOS), decreased ATP production, reduced mitophagy, decreased mtDNA copy number, and activation of mitochondrial apoptosis. These alterations in mitochondrial metabolism were associated with changes in tumor phenotype and in pathways involved in cell mitophagy, mitochondrial apoptosis, and epigenetic regulation. We further showed that the RNA-shuttling protein HuR and the mitochondria transmembrane protein MTCH2 mediated the transport of MALAT1 in this nuclear-mitochondrial crosstalk. This study provides the first evidence that the nuclear genome-encoded lncRNA MALAT1 functions as a critical epigenetic player in the regulation of mitochondrial metabolism of hepatoma cells, laying the foundation for further clarifying the roles of lncRNAs in tumor metabolic reprogramming.